Cargando…

Blood-biomarkers and devices for atrial fibrillation screening: Lessons learned from the AFRICAT (Atrial Fibrillation Research In CATalonia) study

BACKGROUND AND OBJECTIVE: AFRICAT is a prospective cohort study intending to develop an atrial fibrillation (AF) screening program through the combination of blood markers, rhythm detection devices, and long-term monitoring in our community. In particular, we aimed to validate the use of NT-proBNP,...

Descripción completa

Detalles Bibliográficos
Autores principales: Palà, Elena, Bustamante, Alejandro, Clúa-Espuny, Josep Lluis, Acosta, Juan, González-Loyola, Felipe, Santos, Sara Dos, Ribas-Segui, Domingo, Ballesta-Ors, Juan, Penalba, Anna, Giralt, Marina, Lechuga-Duran, Iñigo, Gentille-Lorente, Delicia, Pedrote, Alonso, Muñoz, Miguel Ángel, Montaner, Joan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9398023/
https://www.ncbi.nlm.nih.gov/pubmed/35998199
http://dx.doi.org/10.1371/journal.pone.0273571
_version_ 1784772253502668800
author Palà, Elena
Bustamante, Alejandro
Clúa-Espuny, Josep Lluis
Acosta, Juan
González-Loyola, Felipe
Santos, Sara Dos
Ribas-Segui, Domingo
Ballesta-Ors, Juan
Penalba, Anna
Giralt, Marina
Lechuga-Duran, Iñigo
Gentille-Lorente, Delicia
Pedrote, Alonso
Muñoz, Miguel Ángel
Montaner, Joan
author_facet Palà, Elena
Bustamante, Alejandro
Clúa-Espuny, Josep Lluis
Acosta, Juan
González-Loyola, Felipe
Santos, Sara Dos
Ribas-Segui, Domingo
Ballesta-Ors, Juan
Penalba, Anna
Giralt, Marina
Lechuga-Duran, Iñigo
Gentille-Lorente, Delicia
Pedrote, Alonso
Muñoz, Miguel Ángel
Montaner, Joan
author_sort Palà, Elena
collection PubMed
description BACKGROUND AND OBJECTIVE: AFRICAT is a prospective cohort study intending to develop an atrial fibrillation (AF) screening program through the combination of blood markers, rhythm detection devices, and long-term monitoring in our community. In particular, we aimed to validate the use of NT-proBNP, and identify new blood biomarkers associated with AF. Also, we aimed to compare AF detection using various wearables and long-term Holter monitoring. METHODS: 359 subjects aged 65–75 years with hypertension and diabetes were included in two phases: Phase I (n = 100) and Phase II (n = 259). AF diagnosis was performed by baseline 12-lead ECG, 4 weeks of Holter monitoring (Nuubo(TM)), and/or medical history. An aptamer array including 1310 proteins was measured in the blood of 26 patients. Candidates were selected according to p-value, logFC and biological function to be tested in verification and validation phases. Several screening devices were tested and compared: AliveCor, Watch BP, MyDiagnostick and Fibricheck. RESULTS: AF was present in 34 subjects (9.47%). The aptamer array revealed 41 proteins with differential expression in AF individuals. TIMP-2 and ST-2 were the most promising candidates in the verification analysis, but none of them was further validated. NT-proBNP (log-transformed) (OR = 1.934; p<0.001) was the only independent biomarker to detect AF in the whole cohort. Compared to an ECG, WatchBP had the highest sensitivity (84.6%) and AUC (0.895 [0.780–1]), while MyDiagnostick showed the highest specificity (97.10%). CONCLUSION: The inclusion and monitoring of a cohort of primary care patients for AF detection, together with the testing of biomarkers and screening devices provided useful lessons about AF screening in our community. An AF screening strategy using rhythm detection devices and short monitoring periods among high-risk patients with high NT-proBNP levels could be feasible.
format Online
Article
Text
id pubmed-9398023
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-93980232022-08-24 Blood-biomarkers and devices for atrial fibrillation screening: Lessons learned from the AFRICAT (Atrial Fibrillation Research In CATalonia) study Palà, Elena Bustamante, Alejandro Clúa-Espuny, Josep Lluis Acosta, Juan González-Loyola, Felipe Santos, Sara Dos Ribas-Segui, Domingo Ballesta-Ors, Juan Penalba, Anna Giralt, Marina Lechuga-Duran, Iñigo Gentille-Lorente, Delicia Pedrote, Alonso Muñoz, Miguel Ángel Montaner, Joan PLoS One Research Article BACKGROUND AND OBJECTIVE: AFRICAT is a prospective cohort study intending to develop an atrial fibrillation (AF) screening program through the combination of blood markers, rhythm detection devices, and long-term monitoring in our community. In particular, we aimed to validate the use of NT-proBNP, and identify new blood biomarkers associated with AF. Also, we aimed to compare AF detection using various wearables and long-term Holter monitoring. METHODS: 359 subjects aged 65–75 years with hypertension and diabetes were included in two phases: Phase I (n = 100) and Phase II (n = 259). AF diagnosis was performed by baseline 12-lead ECG, 4 weeks of Holter monitoring (Nuubo(TM)), and/or medical history. An aptamer array including 1310 proteins was measured in the blood of 26 patients. Candidates were selected according to p-value, logFC and biological function to be tested in verification and validation phases. Several screening devices were tested and compared: AliveCor, Watch BP, MyDiagnostick and Fibricheck. RESULTS: AF was present in 34 subjects (9.47%). The aptamer array revealed 41 proteins with differential expression in AF individuals. TIMP-2 and ST-2 were the most promising candidates in the verification analysis, but none of them was further validated. NT-proBNP (log-transformed) (OR = 1.934; p<0.001) was the only independent biomarker to detect AF in the whole cohort. Compared to an ECG, WatchBP had the highest sensitivity (84.6%) and AUC (0.895 [0.780–1]), while MyDiagnostick showed the highest specificity (97.10%). CONCLUSION: The inclusion and monitoring of a cohort of primary care patients for AF detection, together with the testing of biomarkers and screening devices provided useful lessons about AF screening in our community. An AF screening strategy using rhythm detection devices and short monitoring periods among high-risk patients with high NT-proBNP levels could be feasible. Public Library of Science 2022-08-23 /pmc/articles/PMC9398023/ /pubmed/35998199 http://dx.doi.org/10.1371/journal.pone.0273571 Text en © 2022 Palà et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Palà, Elena
Bustamante, Alejandro
Clúa-Espuny, Josep Lluis
Acosta, Juan
González-Loyola, Felipe
Santos, Sara Dos
Ribas-Segui, Domingo
Ballesta-Ors, Juan
Penalba, Anna
Giralt, Marina
Lechuga-Duran, Iñigo
Gentille-Lorente, Delicia
Pedrote, Alonso
Muñoz, Miguel Ángel
Montaner, Joan
Blood-biomarkers and devices for atrial fibrillation screening: Lessons learned from the AFRICAT (Atrial Fibrillation Research In CATalonia) study
title Blood-biomarkers and devices for atrial fibrillation screening: Lessons learned from the AFRICAT (Atrial Fibrillation Research In CATalonia) study
title_full Blood-biomarkers and devices for atrial fibrillation screening: Lessons learned from the AFRICAT (Atrial Fibrillation Research In CATalonia) study
title_fullStr Blood-biomarkers and devices for atrial fibrillation screening: Lessons learned from the AFRICAT (Atrial Fibrillation Research In CATalonia) study
title_full_unstemmed Blood-biomarkers and devices for atrial fibrillation screening: Lessons learned from the AFRICAT (Atrial Fibrillation Research In CATalonia) study
title_short Blood-biomarkers and devices for atrial fibrillation screening: Lessons learned from the AFRICAT (Atrial Fibrillation Research In CATalonia) study
title_sort blood-biomarkers and devices for atrial fibrillation screening: lessons learned from the africat (atrial fibrillation research in catalonia) study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9398023/
https://www.ncbi.nlm.nih.gov/pubmed/35998199
http://dx.doi.org/10.1371/journal.pone.0273571
work_keys_str_mv AT palaelena bloodbiomarkersanddevicesforatrialfibrillationscreeninglessonslearnedfromtheafricatatrialfibrillationresearchincataloniastudy
AT bustamantealejandro bloodbiomarkersanddevicesforatrialfibrillationscreeninglessonslearnedfromtheafricatatrialfibrillationresearchincataloniastudy
AT cluaespunyjoseplluis bloodbiomarkersanddevicesforatrialfibrillationscreeninglessonslearnedfromtheafricatatrialfibrillationresearchincataloniastudy
AT acostajuan bloodbiomarkersanddevicesforatrialfibrillationscreeninglessonslearnedfromtheafricatatrialfibrillationresearchincataloniastudy
AT gonzalezloyolafelipe bloodbiomarkersanddevicesforatrialfibrillationscreeninglessonslearnedfromtheafricatatrialfibrillationresearchincataloniastudy
AT santossarados bloodbiomarkersanddevicesforatrialfibrillationscreeninglessonslearnedfromtheafricatatrialfibrillationresearchincataloniastudy
AT ribasseguidomingo bloodbiomarkersanddevicesforatrialfibrillationscreeninglessonslearnedfromtheafricatatrialfibrillationresearchincataloniastudy
AT ballestaorsjuan bloodbiomarkersanddevicesforatrialfibrillationscreeninglessonslearnedfromtheafricatatrialfibrillationresearchincataloniastudy
AT penalbaanna bloodbiomarkersanddevicesforatrialfibrillationscreeninglessonslearnedfromtheafricatatrialfibrillationresearchincataloniastudy
AT giraltmarina bloodbiomarkersanddevicesforatrialfibrillationscreeninglessonslearnedfromtheafricatatrialfibrillationresearchincataloniastudy
AT lechugaduraninigo bloodbiomarkersanddevicesforatrialfibrillationscreeninglessonslearnedfromtheafricatatrialfibrillationresearchincataloniastudy
AT gentillelorentedelicia bloodbiomarkersanddevicesforatrialfibrillationscreeninglessonslearnedfromtheafricatatrialfibrillationresearchincataloniastudy
AT pedrotealonso bloodbiomarkersanddevicesforatrialfibrillationscreeninglessonslearnedfromtheafricatatrialfibrillationresearchincataloniastudy
AT munozmiguelangel bloodbiomarkersanddevicesforatrialfibrillationscreeninglessonslearnedfromtheafricatatrialfibrillationresearchincataloniastudy
AT montanerjoan bloodbiomarkersanddevicesforatrialfibrillationscreeninglessonslearnedfromtheafricatatrialfibrillationresearchincataloniastudy